Huisong Lee

Dr. Huisong Lee


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2014 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
HLHuisong Lee
Huisong Lee
DCDong Wook Choi
Dong Wook Choi
JPJin Young Park
Jin Young Park
SYSangmin Youn
Sangmin Youn
WKWooil Kwon
Wooil Kwon
KJKee-Taek Jang
Kee-Taek Jang

21 March 2015 in World Journal of Gastroenterology
Verified
Journal Article
Open access
HLHuisong Lee
Huisong Lee
JHJin Seok Heo
Jin Seok Heo
YCYong Beom Cho
Yong Beom Cho
SYSeong Hyeon Yun
Seong Hyeon Yun
HKHee Cheol Kim
Hee Cheol Kim
DCDong Wook Choi
Dong Wook Choi
AIM: To compare outcomes from radiofrequency ablation (RFA) and hepatectomy for treatment of colorectal liver metastasis (CRLM). METHODS: From January 2000 to December 2009, 408 patients underwent curative intent treatment for CRLM. We excluded patients using the criteria: size of CRLM > 3 cm, number of CRLM ≥ 5, percutaneous RFA, follow-up period < 12 mo, double primary cancer, or treatment with both RFA and hepatectomy. We matched 51 patients who underwent RFA with 102 patients who underwent hepatectomy by propensity scores. RESULTS: The median follow-up period was 45 mo (range, 12 mo to 158 mo). Hepatic recurrence was more frequent in the RFA than the hepatectomy group (P = 0.021) although extrahepatic recurrence curves were similar (P = 0.716). Survival curves of hepatectomy group were better than that of RFA for multiple, large (> 2 cm) CRLM (P = 0.034). However, survival curves were similar for single or small (≤ 2 cm) CRLM (P = 0.714, P = 0.740). CONCLUSION: Hepatectomy is better than RFA for the treatment of CRLM. However, RFA might be suitable for selected patients with single, small (≤ 2 cm) CRLM.

6 November 2015 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
HLHuisong Lee
Huisong Lee
JPJin Young Park
Jin Young Park
WKWooil Kwon
Wooil Kwon
JHJin Seok Heo
Jin Seok Heo
DCDong Wook Choi
Dong Wook Choi
SCSeong Ho Choi
Seong Ho Choi

5 February 2014 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
HLHuisong Lee
Huisong Lee
DCDong Wook Choi
Dong Wook Choi
YCYong Beom Cho
Yong Beom Cho
SYSeong Hyeon Yun
Seong Hyeon Yun
HKHee Cheol Kim
Hee Cheol Kim
HCHo-Kyung Chun
Ho-Kyung Chun

1 October 2020 in Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
WKWooil Kwon
Wooil Kwon
JJJin-Young Jang
Jin-Young Jang
KSKi Byung Song
Ki Byung Song
DHDae Wook Hwang
Dae Wook Hwang
SKSong Cheol Kim
Song Cheol Kim
HKHee Joon Kim
Hee Joon Kim
Introduction: The prognostic factors of pancreatic neuroendocrine tumor (PNET) are unclear, and the treatment guidelines are insufficient. This study aimed to suggest a treatment algorithm for PNET based on risk factors for recurrence in a large cohort. Methods: Data of 918 patients who underwent curative intent surgery for PNET were collected from 14 tertiary centers. Risk factors for recurrence and survival analyses were performed. Results: The 5-year disease-free survival (DFS) rate was 86.5%. Risk factors for recurrence included margin status (R1, hazard ratio [HR] 2.438; R2, HR 3.721), 2010 WHO grade (G2, HR 3.864; G3, HR 7.352), and N category (N1, HR 2.273). A size of 2 cm was significant in the univariate analysis (HR 8.511) but not in the multivariate analysis (p = 0.407). Tumor size was not a risk factor for recurrence, but strongly reflected 2010 WHO grade and lymph node (LN) status. Tumors ≤2 cm had lower 2010 WHO grade, less LN metastasis (p < 0.001), and significantly longer 5-year DFS (77.9 vs. 98.2%, p < 0.001) than tumors >2 cm. The clinicopathologic features of tumors <1 and 1-2 cm were similar. However, the LN metastasis rate was 10.3% in 1-2-cm sized tumors and recurrence occurred in 3.0%. Tumors <1 cm in size did not have any LN metastasis or recurrence. Discussion/Conclusion: Radical surgery is needed in suspected LN metastasis or G3 PNET or tumors >2 cm. Surveillance for <1-cm PNETs should be sufficient. Tumors sized 1-2 cm require limited surgery with LN resection, but should be converted to radical surgery in cases of doubtful margins or LN metastasis.

21 February 2015 in World Journal of Gastroenterology
Verified
Journal Article
Open access
HLHuisong Lee
Huisong Lee
SCSeong Ho Choi
Seong Ho Choi
YCYong Beom Cho
Yong Beom Cho
SYSeong Hyeon Yun
Seong Hyeon Yun
HKHee Cheol Kim
Hee Cheol Kim
HCHo-Kyung Chun
Ho-Kyung Chun
AIM: To investigate the survival outcomes of secondary hepatectomy for recurrent colorectal liver metastases (CRLM). METHODS: From October 1994 to December 2009, patients with CRLM who underwent surgical treatment with curative intent were investigated. Patients were divided into two groups: patients who underwent primary hepatectomy (Group 1) and those who underwent secondary hepatectomy for recurrent CRLM (Group 2). RESULTS: Survival and prognostic factors were analyzed. A total of 461 patients were included: 406 patients in Group 1 and 55 patients in Group 2. After a median 39-mo (range, 3-195 mo) follow-up, there was a significant difference between Groups 1 and 2 in terms of disease-free survival (P = 0.029) although there was no significant difference in overall survival (P = 0.206). Secondary hepatectomy was less effective in patients with multiple recurrent CRLM than primary hepatectomy for initial CRLM (P = 0.008). Multiple CRLM and radiofrequency ablation therapy were poor prognostic factors of secondary hepatectomy in multivariate Cox regression analysis (P = 0.006, P = 0.004, respectively). CONCLUSION: Secondary hepatectomy for single recurrent CRLM is as effective as primary surgical treatment for single recurrent CRLM. However, secondary hepatectomy for multiple recurrent CRLM is less effective than that for single recurrent CRLM.